【摘 要】
：
Background We sought to evaluate the impact of biodegradable polymer drug-eluting stent (DES) on the frequency of clinical outcomes,especially stent thrombosis (ST),in randomized trials compared with
【机 构】
：
Nanjing First Hospital,Nanjing Medical University,Nanjing,China
【出 处】
：
第十二届中国介入心脏病学大会(CIT2014)
论文部分内容阅读
Background We sought to evaluate the impact of biodegradable polymer drug-eluting stent (DES) on the frequency of clinical outcomes,especially stent thrombosis (ST),in randomized trials compared with durable polymer DES.Methods We searched Medline,the Cochrane Library and other internet sources,without language or date restrictions for articles comparing clinical outcomes between biodegradable polymer DES and durable polymer DES.Safety endpoints were ST (definite,definite/probable),mortality,and myocardial infarction (MI).Efficacy endpoints were major adverse cardiac event (MACE) and target lesion revascularization (TLR).
其他文献
Background This study was to investigate association of basal metabolic rate with risk of the Rate of carotid artery plaque in Uygur,Kazakh and Han populations of Xinjiang.Methods During the period of
Background This study was a prospective clinical trial designed to compare intensive medical treatment,primary stent placement (PCI),and surgical myocardial revascularization (CABG) for patients with
Background Biodegradable polymers used as vascular stent coatings and stent platforms encounter a major challenge: biocompatibility in vivo,which plays an important role in in-stent restenosis (ISR).C
Background TARGET Ⅰ randomized controlled trial demonstrated that the novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent FIREHAWK (MicroPort Medical,Shanghai,China) was non-in
Background TARGET Ⅰ randomized controlled trial demonstrated that the novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent FIREHAWK (MicroPort Medical,Shanghai,China) was non-in
Background Ischemic postconditioning has been reported to reduce infarct size in patients with ST-segment-elevation myocardial infarction.However,the long-term cardioprotective effects of postconditio
Background The present study is to compare the clinical performance of EES and other limus drugs eluting stents (namely,BES,ZES,and SES),using data from randomized controlled trials (RCTs).Methods We
Background Cystatin C (Cys C) is a marker ofrenat dysfunction.Prior studies have shown that blood Cys C is related to the prognosis of coronary heart disease.The aim of the present study was to evalua
Background Both selenium (Se) deficiency and supplementation resulted in multiple detrimental effects in human and animals.The GPx-1 (Pro198Leu) polymorphism is associated with Se deficiency as well a
Background The study sought to assess the five-year clinical impact of complete (CR),incomplete (ICR) revascularization,and reasonable ICR (R-ICR) in patients with unprotected left main coronary arter